Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.56	6.07	9.29	13.52	15.19
Short-Term Investments	2.8	8.2	10.49	26.37	45.98
Cash & Short-Term Investments	10.37	14.27	19.78	39.89	61.16
Cash Growth	-27.34%	-27.89%	-50.41%	-34.77%	422.83%
Other Current Assets	3.06	1.77	1.11	1.84	1.53
Total Current Assets	13.43	16.04	20.9	41.74	62.69
Net Property, Plant & Equipment	0.18	0.54	0.7	0.59	0.7
Other Long-Term Assets	0.21	0.39	0.56	0.73	0.96
Total Assets	13.81	16.96	22.15	43.06	64.35
Accounts Payable	0.49	0.63	0.52	1.69	1.34
Accrued Expenses	0.99	2.47	4.25	4.94	1.21
Current Portion of Leases	-	0.12	0.08	0.12	0.11
Total Current Liabilities	1.48	3.22	4.84	6.75	2.65
Long-Term Leases	-	0.21	0.32	0.09	0.24
Total Long-Term Liabilities	-	0.21	0.32	0.09	0.24
Total Liabilities	1.48	3.43	5.15	6.84	2.89
Treasury Stock	-	-	-	-1.22	-
Additional Paid-in Capital	123.95	116.16	105.68	101.26	97.64
Retained Earnings	-111.62	-102.62	-88.68	-63.82	-36.17
Shareholders' Equity	12.33	13.54	17	36.22	61.47
Total Liabilities & Equity	13.81	16.96	22.15	43.06	64.35
Total Debt	0	0.32	0.39	0.21	0.34
Net Cash (Debt)	10.37	13.94	19.39	39.68	60.82
Net Cash Growth	-25.65%	-28.10%	-51.13%	-34.76%	439.64%
Net Cash Per Share	1.63	3.11	6.60	13.95	23.45
Book Value	12.33	13.54	17	36.22	61.47
Book Value Per Share	1.93	3.02	5.79	12.73	23.70
Tangible Book Value	12.33	13.54	17	36.22	61.47
Tangible Book Value Per Share	1.93	3.02	5.79	12.73	23.70

Updated Mar 20, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q